![NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines](https://cdn.cancerletter.com/media/2024/06/14130725/50-24-4x3-1.jpg)
![NCI faces prospect of an 11% cut in FY25—another setback in a period of tight budgets and sliding paylines](https://cdn.cancerletter.com/media/2024/06/14130725/50-24-4x3-1.jpg)
Cover Story
NCI Director's Report
By Matthew Bin Han Ong
After a year of lean appropriations, NCI is looking at what threatens to be a budgetary cataclysm—a potential 10-11% cut to the Labor-HHS spending bill in fiscal year 2025.
In Brief
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
![In Brief](https://cdn.cancerletter.com/media/2019/05/03155624/in-brief-3.jpg)
Clinical Roundup
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
![Clinical Roundup](https://cdn.cancerletter.com/media/2019/05/03161627/clinical_roundup.jpg)
Drugs & Targets
Trending Stories
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - “All in Her Head” catalogs the history of medicine’s atrocities against women
- Chernobyl: a 35 year follow up on long-term health effects
- Wafik El-Deiry carted a bunch of books around the Mediterranean
Here are his reviews - What are you reading in 2024?
- Suspensions, public outrage ensue as tensions over Middle East sweep through oncology
NYU Cancer Center Director Benjamin Neel suspended over social media posts